Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-[[(2r)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2. [(2r)-2,3-dihydroxypropoxy][2-(trimethylazaniumyl)ethoxy]phosphinic Acid
3. Ch5
4. Glycero-3-phosphocholine
5. Choline-alfoscerate
6. Schembl157824
7. O-(l-glycero-3-phospho)choline
8. Zinc1532714
9. S4972
10. C00670
11. A929212
12. Q27458810
13. 2-{[(s)-{[(2r)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-n,n,n-trimethylethanaminium
Molecular Weight | 258.23 g/mol |
---|---|
Molecular Formula | C8H21NO6P+ |
XLogP3 | -2.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 8 |
Exact Mass | 258.11064939 g/mol |
Monoisotopic Mass | 258.11064939 g/mol |
Topological Polar Surface Area | 96.2 Ų |
Heavy Atom Count | 16 |
Formal Charge | 1 |
Complexity | 241 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23645
Submission : 2010-03-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8817
Submission : 1990-11-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29128
Submission : 2015-03-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32551
Submission : 2018-02-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32550
Submission : 2018-02-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8691
Submission : 1990-08-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16614
Submission : 2003-05-22
Status : Active
Type : II
Registrant Name : Dasan Pharmaceutical Co., Ltd.
Registration Date : 2019-08-01
Registration Number : 20190801-168-I-594-28
Manufacturer Name : Dasan Pharmaceutical Co., Lt...
Manufacturer Address : 342 Deokamsan-ro, Dogo-myeon, Asan-si, Chungcheongnam-do @ [Starting material: cholin...
Registrant Name : HS Bio Co., Ltd.
Registration Date : 2019-04-18
Registration Number : 20190418-168-I-584-25
Manufacturer Name : HS Bio Co., Ltd.
Manufacturer Address : HS Bio Co., Ltd., 57, Sincheoksandan 4-ro, Deoksan-eup, Jincheon-gun, Chungcheongbuk-...
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2021-06-01
Registration Number : 20210601-168-I-620-33
Manufacturer Name : Hunan Jiudian Pharmaceutical...
Manufacturer Address : Hunan Liuyang Bio-Pharmaceutical Park, Changsha, Hunan, 410329, PR of China
Registrant Name : Otran Korea Co., Ltd.
Registration Date : 2022-05-04
Registration Number : 20220504-168-I-634-34
Manufacturer Name : Hunan Warrant Chiral Pharmac...
Manufacturer Address : No.139, Tongguan Avenue, Tongguan Circular Economy Industrial Park, Wangcheng Distric...
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2020-03-12
Registration Number : 20200312-168-I-588-30
Manufacturer Name : Hunan Warrant Chiral Pharmac...
Manufacturer Address : 57, Yakjeonggongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do @No.139 , Tongguan ...
Registrant Name : Hawon Precision Chemical Co., Ltd.
Registration Date : 2020-07-07
Registration Number : 20200707-168-I-606-31
Manufacturer Name : Hawon Precision Chemical Co....
Manufacturer Address : 53-10 Nojang Industrial Complex-gil, Jeondong-myeon, Sejong Special Self-Governing Ci...
Registrant Name : Korea Prime Pharmaceutical Co., Ltd.
Registration Date : 2021-03-03
Registration Number : 20210303-168-I-619-32
Manufacturer Name : Korea Prime Pharmaceutical C...
Manufacturer Address : 209, Wanju Industrial Complex 6-ro, Bongdong-eup, Wanju-gun, Jeollabuk-do Special Sel...
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2019-05-21
Registration Number : 20190521-168-I-586-26
Manufacturer Name : R&R Extrakte GmbH
Manufacturer Address : Nattermannallee 1, 50829 Koln, Germany
Registrant Name : Pharmacostec Co., Ltd.
Registration Date : 2019-09-19
Registration Number : 20190919-168-I-596-29
Manufacturer Name : Pharmacostech Co., Ltd. @ IT...
Manufacturer Address : 47, Pharmaceutical Complex, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Block 35-2, Balan...
Registrant Name : Shin Poong Pharmaceutical Co., Ltd.
Registration Date : 2018-07-18
Registration Number : 20180718-168-I-569-24
Manufacturer Name : Shinpoong Pharmaceutical Co....
Manufacturer Address : 7, Wonsi-ro, Danwon-gu, Ansan-si, Gyeonggi-do @ [Product manufacturer] Hunan Liuyang ...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Ukraine
Brand Name : Gliaton
Dosage Form : Solution for Injection
Dosage Strength : 250MG/ML
Packaging : 4ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Ukraine
Brand Name : Gliaton
Dosage Form : Soft Gel Capsule
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Italy
Brand Name : Gliatilin
Dosage Form :
Dosage Strength : 14 Cps 400 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Gliatilin
Dosage Form :
Dosage Strength : 5 Ampoules Im Ev 1 G/4 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : INJECTABLE
Dosage Strength : 1000MG/4ML
Packaging : 3 Ampoules
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : SOFT CAPSULE
Dosage Strength : 400MG
Packaging : 14 Capsules
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Italy
Brand Name : Delecit
Dosage Form :
Dosage Strength : 14 Cps 400 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Delecit
Dosage Form :
Dosage Strength : Os Soluz 10 Vials 600 Mg 7 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Delecit
Dosage Form :
Dosage Strength : 3 Ampoules Im Ev 1 G/4 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Ukraine
Brand Name : Alphacholine
Dosage Form : Injection
Dosage Strength : 1000MG/4ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 1000MG/4ML
Brand Name : Alphacholine
Approval Date :
Application Number :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Ukraine
Brand Name : Alphacholine
Dosage Form : Solution
Dosage Strength : 600MG/7ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Packaging :
Regulatory Info :
Dosage : Solution
Dosage Strength : 600MG/7ML
Brand Name : Alphacholine
Approval Date :
Application Number :
Registration Country : Ukraine
Regulatory Info :
Registration Country : South Korea
Brand Name : Coline-K Solution
Dosage Form : Solution
Dosage Strength : 400MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging :
Regulatory Info :
Dosage : Solution
Dosage Strength : 400MG/10ML
Brand Name : Coline-K Solution
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic B.E study
Registration Country : South Korea
Brand Name : Newraren
Dosage Form : TABLET
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic B.E study
Registration Country : South Korea
Packaging :
Regulatory Info : Generic B.E study
Dosage : TABLET
Dosage Strength : 400MG
Brand Name : Newraren
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Brand Name : Alfocetine
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 400MG
Brand Name : Alfocetine
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : Turkey
Brand Name : MEDOTILIN
Dosage Form : INJECTABLE
Dosage Strength : 1000MG/4ML
Packaging : 3 AMPULES
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 3 AMPULES
Regulatory Info :
Dosage : INJECTABLE
Dosage Strength : 1000MG/4ML
Brand Name : MEDOTILIN
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : MEDOTILIN
Dosage Form : SOFT CAPSULE
Dosage Strength : 400MG
Packaging : 14 CAPSULES
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 14 CAPSULES
Regulatory Info :
Dosage : SOFT CAPSULE
Dosage Strength : 400MG
Brand Name : MEDOTILIN
Approval Date :
Application Number :
Registration Country : Turkey
Global Sales Information
Market Place
Reply
05 Jun 2025
Reply
08 Nov 2023
Reply
26 Aug 2021
Reply
31 Mar 2021
Reply
04 Sep 2019
Reply
05 Apr 2021
Reply
09 Jun 2020
ABOUT THIS PAGE
88
PharmaCompass offers a list of Glycerylphosphorylcholine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glycerylphosphorylcholine manufacturer or Glycerylphosphorylcholine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glycerylphosphorylcholine manufacturer or Glycerylphosphorylcholine supplier.
PharmaCompass also assists you with knowing the Glycerylphosphorylcholine API Price utilized in the formulation of products. Glycerylphosphorylcholine API Price is not always fixed or binding as the Glycerylphosphorylcholine Price is obtained through a variety of data sources. The Glycerylphosphorylcholine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L alpha Glycerylphosphorylcholine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L alpha Glycerylphosphorylcholine, including repackagers and relabelers. The FDA regulates L alpha Glycerylphosphorylcholine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L alpha Glycerylphosphorylcholine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L alpha Glycerylphosphorylcholine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L alpha Glycerylphosphorylcholine supplier is an individual or a company that provides L alpha Glycerylphosphorylcholine active pharmaceutical ingredient (API) or L alpha Glycerylphosphorylcholine finished formulations upon request. The L alpha Glycerylphosphorylcholine suppliers may include L alpha Glycerylphosphorylcholine API manufacturers, exporters, distributors and traders.
click here to find a list of L alpha Glycerylphosphorylcholine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L alpha Glycerylphosphorylcholine DMF (Drug Master File) is a document detailing the whole manufacturing process of L alpha Glycerylphosphorylcholine active pharmaceutical ingredient (API) in detail. Different forms of L alpha Glycerylphosphorylcholine DMFs exist exist since differing nations have different regulations, such as L alpha Glycerylphosphorylcholine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L alpha Glycerylphosphorylcholine DMF submitted to regulatory agencies in the US is known as a USDMF. L alpha Glycerylphosphorylcholine USDMF includes data on L alpha Glycerylphosphorylcholine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L alpha Glycerylphosphorylcholine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L alpha Glycerylphosphorylcholine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a L alpha Glycerylphosphorylcholine Drug Master File in Korea (L alpha Glycerylphosphorylcholine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of L alpha Glycerylphosphorylcholine. The MFDS reviews the L alpha Glycerylphosphorylcholine KDMF as part of the drug registration process and uses the information provided in the L alpha Glycerylphosphorylcholine KDMF to evaluate the safety and efficacy of the drug.
After submitting a L alpha Glycerylphosphorylcholine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their L alpha Glycerylphosphorylcholine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of L alpha Glycerylphosphorylcholine suppliers with KDMF on PharmaCompass.
A L alpha Glycerylphosphorylcholine written confirmation (L alpha Glycerylphosphorylcholine WC) is an official document issued by a regulatory agency to a L alpha Glycerylphosphorylcholine manufacturer, verifying that the manufacturing facility of a L alpha Glycerylphosphorylcholine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting L alpha Glycerylphosphorylcholine APIs or L alpha Glycerylphosphorylcholine finished pharmaceutical products to another nation, regulatory agencies frequently require a L alpha Glycerylphosphorylcholine WC (written confirmation) as part of the regulatory process.
click here to find a list of L alpha Glycerylphosphorylcholine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L alpha Glycerylphosphorylcholine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L alpha Glycerylphosphorylcholine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L alpha Glycerylphosphorylcholine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L alpha Glycerylphosphorylcholine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L alpha Glycerylphosphorylcholine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L alpha Glycerylphosphorylcholine suppliers with NDC on PharmaCompass.
L alpha Glycerylphosphorylcholine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L alpha Glycerylphosphorylcholine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L alpha Glycerylphosphorylcholine GMP manufacturer or L alpha Glycerylphosphorylcholine GMP API supplier for your needs.
A L alpha Glycerylphosphorylcholine CoA (Certificate of Analysis) is a formal document that attests to L alpha Glycerylphosphorylcholine's compliance with L alpha Glycerylphosphorylcholine specifications and serves as a tool for batch-level quality control.
L alpha Glycerylphosphorylcholine CoA mostly includes findings from lab analyses of a specific batch. For each L alpha Glycerylphosphorylcholine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L alpha Glycerylphosphorylcholine may be tested according to a variety of international standards, such as European Pharmacopoeia (L alpha Glycerylphosphorylcholine EP), L alpha Glycerylphosphorylcholine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L alpha Glycerylphosphorylcholine USP).